Human fibrinogen (Sinopharm Shanghai Plasma)
人纤维蛋白原（国药上海血液）
Report date: 2022/04/19 13:32:04
Base Information
Drug NameHuman fibrinogen (Sinopharm Shanghai Plasma)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1997/01/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesSinopharm Shanghai Plasma-Derived Biotherapies Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A